Suppr超能文献

炎症性肠病和艰难梭菌感染患者内镜下假膜的患病率及临床影响。

Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection.

机构信息

Sheba Medical Center, Tel-Aviv University, Israel.

出版信息

J Crohns Colitis. 2010 Jun;4(2):194-8. doi: 10.1016/j.crohns.2009.11.001. Epub 2009 Nov 22.

Abstract

BACKGROUND AND AIM

Limited data suggests that pseudomembranes are uncommon in patients with inflammatory bowel disease (IBD) and C. difficile associated disease (CDAD), but the reason for this is unknown. We aimed to evaluate the rate of pseudomembranes in this population, identify predictive factors for pseudomembranes' presence and assess its clinical impact.

METHODS

This was a sub-study of a retrospective European Crohn's & Colitis Organization (ECCO) multi-center study on the outcome of hospitalized IBD patients with C. difficile. The present study included only patients who underwent lower endoscopy during hospitalization, and compared demographic and clinical parameters in the group of patients with discernable pseudomembranes versus those without.

RESULTS

Out of 155 patients in the original cohort, 93 patients underwent lower endoscopy and constituted the study population. Endoscopic pseudomembranes were found in 12 (13%) of these patients. Patients with pseudomembranes presented more commonly with fever (p=0.02) compared to patients without pseudomembranes. No difference between the two groups was found with respect to the use of immunosuppressant drugs, background demographics or disease characteristics. Neither was there a difference between the group with or without pseudomembranes in the frequency of severe adverse clinical outcome or in the duration of hospitalization. On multi-variate analysis the presence of fever remained independently associated with the finding of pseudomembranes (OR 6, 95% CI 1.2-32, p=0.03).

CONCLUSIONS

This study documents that hospitalized IBD patients with CDAD have low rate of endoscopic pseudomembranes, which is not accounted for by the use of immunosuppressant drugs. IBD patients with CDAD and discernable pseudomembranes more commonly present with fever, but their clinical outcome is similar to patients without pseudomembranes.

摘要

背景与目的

有限的数据表明,在炎症性肠病(IBD)和艰难梭菌相关疾病(CDAD)患者中,假膜并不常见,但原因尚不清楚。我们旨在评估该人群中假膜的发生率,确定假膜存在的预测因素,并评估其临床影响。

方法

这是一项回顾性的欧洲克罗恩病和结肠炎组织(ECCO)多中心研究的子研究,该研究旨在评估住院 IBD 合并艰难梭菌患者的结局。本研究仅纳入了在住院期间接受下内镜检查的患者,并比较了有和无假膜的患者的人口统计学和临床参数。

结果

在原始队列的 155 名患者中,93 名患者接受了下内镜检查,构成了研究人群。在这些患者中,12 名(13%)患者发现内镜下假膜。与无假膜的患者相比,有假膜的患者更常见发热(p=0.02)。两组在免疫抑制剂药物的使用、背景人口统计学或疾病特征方面没有差异。有假膜和无假膜的患者在严重不良临床结局的频率或住院时间方面也没有差异。多变量分析显示,发热的存在与假膜的发现独立相关(OR 6,95%CI 1.2-32,p=0.03)。

结论

本研究表明,合并 CDAD 的住院 IBD 患者内镜下假膜发生率较低,这与免疫抑制剂药物的使用无关。有 CDAD 和可识别假膜的 IBD 患者更常出现发热,但他们的临床结局与无假膜的患者相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验